At the end of 2019, Prime Therapeutics, LLC (“Prime”) announced that it had entered into a three-year supply chain agreement with Express Scripts, Inc. (“ESI”) “to focus on enhancing pharmacy networks and pharmaceutical manufacturer... Read More
On July 30, 2019, the Commonwealth of Puerto Rico passed the Pharmacy Services and Benefit Managers Regulatory Act (the “Act”), and the relevant portions of the Act took effect in November 2019. Its effects may have gone largely unacknowledged... Read More
On April 30, 2020, the Food and Drug Administration (FDA) issued new guidance relaxing certain requirements under the Drug Supply Chain Security Act (DSCSA) for COVID-19 related drug products. In the guidance, FDA explained that under the DSCSA... Read More
https://www.youtube.com/watch?v=G2-iGKlATyU&feature=youtu.be In these trying times many pharmacies and medical practices are facing some degree of temporary shutdowns. Co-Founding Partner Jonathan Levitt, Esq. and our Managing Partner of our... Read More
In May 2019, Oklahoma passed the Patient Right to Pharmacy Care Act ("Act"). The Act takes aim at unfair pharmacy benefit manager (“PBM”) practices by expanding network access for independent pharmacies, prohibiting PBMs from requiring patients... Read More
In an effort to facilitate continuity of patient care and to respond appropriately to the circumstances that have arisen during the COVID-19 pandemic, the Drug Enforcement Administration (“DEA”) has recently announced three exceptions to DEA... Read More
Pharmacists are frequently the first point of contact with a healthcare provider for many Americans. In an effort to implement large-scale testing for COVID-19, on April 8, 2020, the Office of the Assistant Secretary of Health, HHS, authorized... Read More
The role of the pharmacist is continuously evolving. President Trump's October 2019 Executive Order 13890, which seeks to improve access to healthcare for Medicare patients, sparked arguments from the National Community Pharmacists Association... Read More
In December 2019, we learned that Prime Therapeutics, LLC (“Prime”) and Express Scripts sought to begin a massive collaborative effort that would cover over 100 million Americans and was “designed to deliver more affordable care for clients... Read More
Much of America is now entering the third week of social distancing, and with the President’s decision to extend Coronavirus mitigation guidelines through the end of April, businesses are bracing for continued interruption. Providers across the... Read More
